SAGU News Today: Stay Updated with the Latest Shreya Acquisition Group News in Real Time
Find SAGU news now at Meyka AI. Stay informed with the latest{" "} Shreya Acquisition Group stocks updates, including price news, market analysis, and expert insights.
Bank of Canada Signals No Quick Fix for Housing Market, June 09
Bank of Canada maintains steady housing policy as debt-stressed households face mortgage renewal challenges and refinancing pressures.
US Strikes Iran After Apache Helicopter Downed, June 10
US military strikes Iran after Apache helicopter downed over Strait of Hormuz. Two pilots rescued safely. Ceasefire at risk as tensions escalate.
Barbeques Galore Liquidates 62 Stores, 500 Jobs Lost on June 10
Barbeques Galore enters liquidation with 62 stores closing and 500 jobs lost after rescue deal collapsed.
Canada Expands Fighter Fleet to 140 Jets With F-35s and Gripens, June 09
Canada plans fighter fleet expansion to 140 jets, including F-35s and Swedish Gripens assembled domestically.
Lufthansa Adds ITA Airways to Europe-Japan Joint Venture, June 10
Lufthansa adds ITA Airways to Europe-Japan joint venture with ANA, effective autumn 2026. Agreement signed June 8 at IATA meeting in Rio.
Germany and France End €100B Fighter Jet Project, June 09
Germany and France cancel €100 billion FCAS fighter jet project after Airbus-Dassault leadership disputes. Combat Cloud may continue separately.
South Korea Blocks Japan Military Pact Over Colonial Apology, June 10
South Korea blocks ACSA military agreement with Japan, citing unresolved colonial history and public opposition to defense cooperation.
United Natural Foods Stock Plunges 11% After $7.72B Revenue Miss and Weak FY2026 Outlook
Revenue came in. The stock came down. United Natural Foods (NYSE: UNFI) reported fiscal Q3 2026 results before the market open on June 9, 2026, covering the 13 weeks ended May 2, 2026. Wall Street had set the bar at $7.80 billion in revenue and $0.77 EPS, based on consensus estimates from 10 analysts. The…
GSK to Buy Nuvalent for $10.6 Billion, Paying $124 Per Share in All-Cash Deal
GSK has made a major move in the global pharmaceutical industry. The company has agreed to acquire Nuvalent for $10.6 billion in an all-cash deal. The offer price is $124 per share, which is about a 40% premium compared to the last closing price of Nuvalent. This is not a small deal. It is one…